68Ga-FAPI PET/CT评估肝硬化患者肝结节
该病例提示68Ga-FAPI PET/CT可能有助于肝硬化患者中良性结节与肝细胞癌的鉴别。
要点
- 肝硬化患者肝实质68Ga-FAPI摄取增高,结节无病理性摄取。
- 结节因活性低于周围肝实质而清晰显示,提示良性。
- 组织病理学证实良性结节,提示68Ga-FAPI PET/CT可能有助于鉴别。
核心结论
- 该病例提示68Ga-FAPI PET/CT可能有助于肝硬化患者中良性结节与肝细胞癌的鉴别。
主要发现
- 肝硬化患者肝实质68Ga-FAPI摄取增高,但结节无病理性68Ga-FAPI摄取。
- 结节因活性低于周围肝实质而清晰显示,68Ga-FAPI PET/CT特征提示良性结节。
- 组织病理学检查 later 证实为良性结节。
关键数值与推荐
- 结节无病理性68Ga-FAPI摄取且活性低于周围肝实质,该特征提示良性结节并获组织病理学证实。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ga-FAPI PET/CT was performed in a 56-year-old cirrhotic patient with multiple liver nodules, which were suspected of hepatocellular carcinoma by contrast-enhanced magnetic resonance but were not visualized by F-FDG PET/CT. Increased Ga-FAPI liver uptake was observed in this cirrhotic patient. However, the nodules had no pathological Ga-FAPI uptake and were clearly visualized due to the low activity compared with surrounding liver parenchyma. The Ga-FAPI PET/CT features, suggestive of benign nodules, have been later confirmed by histopathological examination. This case suggested that Ga-FAPI PET/CT may be useful in the differentiation between benign nodules and hepatocellular carcinoma in the patient with liver cirrhosis.
引用
- Zhao L, Gu J, Fu K, et al. 68Ga-FAPI PET/CT in Assessment of Liver Nodules in a Cirrhotic Patient. Clin Nucl Med. 2020. PMID: 32332301. doi:10.1097/RLU.0000000000003015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。